Ebola Outbreak: It is Ethical to Use Untested Drugs for Treatment, declared UN

By  ,  Onlymyhealth editorial team
Aug 13, 2014

Subscribe for daily wellness inspiration

Like onlymyhealth on Facebook!

Ebola Outbreak In West AfricaFollowing the Ebola outbreak, the World Health Organization (WHO) declared that there is nothing unethical with using untested drugs and vaccines in West Africa. The little supply of one experimental treatment is no more available in the area though and it may take months to make it available once again.

A UK-based public relations firm that represents Liberia said that the last drug is on its way to the West African country for two doctors who have been stricken.

The US manufacturer of the drug said that the supply has been ‘exhausted’. Meanwhile on Tuesday, Canada said that it will provide some of its experimental vaccine for use in West Africa.

The third person to receive the experimental treatment called ZMapp was a Spanish missionary priest who died yesterday.

However, two US aid workers who received the treatment recently are said to be showing improvement.

The death toll so far has reached over 1,000 which include people from countries like Guinea, Sierra Leone, Liberia, and
Nigeria making the outbreak the biggest in history.

A proven and tested treatment for Ebola is yet to be established. Some of the treatments are in their early stages though. ZMapp which has been manufactured by Mapp pharmaceuticals is a new treatment which was never tested on humans before. However, a version was worked in some monkeys who suffered from Ebola. The vaccine is aimed at boosting the immune system to fight against Ebola.

An assistant director-general at WHO, Dr. Marie-Paule Kieny said in a press conference at Geneva "if there are drugs that can save lives - as animal studies have suggested - shouldn't we use them to save lives?".

Image courtesy: Getty Images

News source: hindustantimes.com

Read more Health News.

Write Comment Read ReviewDisclaimer
Is it Helpful Article?YES1 Vote 921 Views 0 Comment